1. Home
  2. SMBK vs IRWD Comparison

SMBK vs IRWD Comparison

Compare SMBK & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SmartFinancial Inc.

SMBK

SmartFinancial Inc.

HOLD

Current Price

$42.34

Market Cap

698.6M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.79

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMBK
IRWD
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
698.6M
663.6M
IPO Year
2000
2009

Fundamental Metrics

Financial Performance
Metric
SMBK
IRWD
Price
$42.34
$4.79
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$43.17
$7.67
AVG Volume (30 Days)
47.7K
1.8M
Earning Date
04-20-2026
05-11-2026
Dividend Yield
0.77%
N/A
EPS Growth
39.25
1400.00
EPS
2.98
0.15
Revenue
N/A
$298,276,000.00
Revenue This Year
$17.59
$57.95
Revenue Next Year
$10.30
$4.39
P/E Ratio
$14.10
$31.07
Revenue Growth
N/A
8.88
52 Week Low
$30.45
$0.55
52 Week High
$43.91
$5.78

Technical Indicators

Market Signals
Indicator
SMBK
IRWD
Relative Strength Index (RSI) 53.81 67.03
Support Level $40.73 $3.07
Resistance Level $43.31 $5.67
Average True Range (ATR) 1.32 0.26
MACD -0.11 0.06
Stochastic Oscillator 42.53 90.09

Price Performance

Historical Comparison
SMBK
IRWD

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: